403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Avai Bio Inc
(MENAFN- Baystreet) 09:54 AM EST - Avai Bio Inc: Announced--together with its joint venture partner and global biotechnology firm, Austrianova--the initiation of production for a Master Cell Bank of genetically modified cells that overexpress the a-Klotho protein. These cells will enable Klothonova, the parties' joint venture, to advance its anti-aging product candidate within the ongoing a-Klotho development program, following the successful completion of all preparatory activities in February. Avai Bio Inc
shares O are trading off $0.02 at $0.38.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
Comments
No comment